 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval) T% p+ n4 }$ J) i; e1 F2 C& O) O
# f1 m* @, C" c7 ^EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.* J2 S: |5 z! B" t4 B* B9 F
( J" [0 k) `2 JBY THE EDMONTON JOURNAL FEBRUARY 16, 2007: o7 B; V6 u6 g6 ?( S% r8 |
) _3 K# J; h! j+ } `- r * b" B$ s- \$ F+ F) ^
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* J, Y7 s+ w. y o: W3 y2 R- H3 v1 d; t0 `1 y0 _3 p5 j
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."5 t# |4 W6 _" K) O8 N
/ S+ @ l8 p9 M% g( V$ b& n
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
3 e' T; Q+ l; z- j
. J% r0 _/ O, s9 p# Y1 cIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
, i8 Y8 C' {! k6 X' X8 z. D* c, M" D2 }9 o2 U' W
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million." }0 K% [ Y$ a C+ }. v( M: z& O
S/ h2 M7 a5 Q' N; d- _( m J
"As a scientist, it's one of the highlights of my CAREER," Shan said.
# x2 |% N" P) d/ `+ R& v. D G: {
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
! A( O0 |6 \+ P7 |( c4 _
1 Z. }+ u2 b3 lIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
) O: O2 c, C; {0 i2 U. Q/ U7 l+ `* Q$ M" N" ~( K4 G0 i5 t
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.9 K3 G, A/ V9 A
" B: ?& G) N! f: K& @7 NThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
$ S( Y& G9 H4 Y$ h' y& W8 [( P, y4 O, p- L
' _6 S9 s `; w0 }( Ihttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|